Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.

Toon andere (1) versies

BACKGROUND: Contemporary screening for prostate cancer frequently identifies small volume, low-grade lesions. Some clinicians have advocated focal prostatic ablation as an alternative to more aggressive interventions to manage these lesions. To identify which patients might benefit from focal ablati...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Catto, J, Robinson, M, Albertsen, P, Goepel, JR, Abbod, M, Linkens, D, Davis, M, Rosario, D, Warren, A, Varma, M, Griffiths, D, Grigor, K, Mayer, N, Oxley, J, Deshmukh, N, Lane, J, Metcalfe, C, Donovan, J, Neal, D, Hamdy, F
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2011

Gelijkaardige items

Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study
door: Catto, J, et al.
Gepubliceerd in: (2011)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
door: Rosario, D, et al.
Gepubliceerd in: (2008)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
door: Lane, J, et al.
Gepubliceerd in: (2004)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
door: Hamdy, FC, et al.
Gepubliceerd in: (2020)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
door: Collin, S, et al.
Gepubliceerd in: (2009)

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study.
door: Burton, A, et al.
Gepubliceerd in: (2013)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
door: Hamdy, F, et al.
Gepubliceerd in: (2006)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT
door: Freddie C Hamdy, et al.
Gepubliceerd in: (2020-08-01)

Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
door: Zuccolo, L, et al.
Gepubliceerd in: (2013)

Association of obesity with prostate cancer: A case-control study within the population-based PSA testing phase of the ProtecT study
door: Dimitropoulou, P, et al.
Gepubliceerd in: (2011)

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study.
door: Dimitropoulou, P, et al.
Gepubliceerd in: (2011)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
door: Rosario, D, et al.
Gepubliceerd in: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
door: Rosario, D, et al.
Gepubliceerd in: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
door: Rosario, D, et al.
Gepubliceerd in: (2012)

Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial
door: Wade, J, et al.
Gepubliceerd in: (2015)

Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received
door: Neal, D, et al.
Gepubliceerd in: (2019)

A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study).
door: Mills, N, et al.
Gepubliceerd in: (2006)

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
door: J. Donovan, et al.
Gepubliceerd in: (2003-01-01)

The ProtecT trial: Analysis of the patient cohort, baseline risk stratification and disease progression
door: Young, GJ, et al.
Gepubliceerd in: (2020)

Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.
door: Mills, N, et al.
Gepubliceerd in: (2003)

Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).
door: Murad, A, et al.
Gepubliceerd in: (2011)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
door: Lane, J, et al.
Gepubliceerd in: (2010)

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
door: S. Sanghera, et al.
Gepubliceerd in: (2020-10-01)

Neuro-fuzzy modeling: an accurate and interpretable method for predicting bladder cancer progression.
door: Catto, J, et al.
Gepubliceerd in: (2006)

Predictive modeling in cancer: where systems biology meets the stock market.
door: Abbod, M, et al.
Gepubliceerd in: (2009)

Comparative study of intelligent models for the prediction of bladder cancer progression.
door: Abbod, M, et al.
Gepubliceerd in: (2006)

Mortality among nen with advanced prostate cancer excluded from the ProtecT Trial
door: Johnston, T, et al.
Gepubliceerd in: (2016)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
door: Avery, K, et al.
Gepubliceerd in: (2007)

Artificial intelligence for the prediction bladder cancer
door: Abbod, M, et al.
Gepubliceerd in: (2004)

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING
door: Burton, A, et al.
Gepubliceerd in: (2011)

Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
door: Catto, J, et al.
Gepubliceerd in: (2009)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
door: Donovan, J, et al.
Gepubliceerd in: (2003)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
door: Lane, J, et al.
Gepubliceerd in: (2009)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
door: Lane, J, et al.
Gepubliceerd in: (2007)

Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial
door: Chris Metcalfe, et al.
Gepubliceerd in: (2020-09-01)

Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
door: Lane, A, et al.
Gepubliceerd in: (2016)

Development of a prognostic marker panel in bladder cancer using aberrant promoter methylation
door: Catto, J, et al.
Gepubliceerd in: (2007)

Post-diagnosis serum insulin-like growth factors in relation to dietary and lifestyle changes in the Prostate testing for cancer and Treatment (ProtecT) trial.
door: Er, V, et al.
Gepubliceerd in: (2017)

Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks.
door: Catto, J, et al.
Gepubliceerd in: (2003)

Decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial.
door: Avery, K, et al.
Gepubliceerd in: (2008)